(Q43614313)

25 November 2017

Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML). (English)

1 reference

25 November 2017

acute myeloid leukemia

1 reference

2

1 reference

25 November 2017

van den Heuvel-Eibrink MM

1

1 reference

25 November 2017

Kuijpers M

3

1 reference

25 November 2017

Pieters R

4

1 reference

25 November 2017

Sonneveld P

5

1 reference

25 November 2017

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

15

1 reference

25 November 2017

855-856

1 reference

25 November 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402112

25 November 2017

0 references

cites work

Low expression of the deoxycytidine kinase (dCK) gene in a 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line KY-Ra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402112

7 January 2021

Deoxycytidine kinase mRNA expression in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402112

7 January 2021

Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402112

7 January 2021

A novel RT-PCR-based protein activity truncation assay for direct assessment of deoxycytidine kinase in small numbers of purified leukemic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402112

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402112

1 reference

Dimensions Publication ID

25 November 2017

0 references

1 reference